ClinVar Genomic variation as it relates to human health
NM_020247.5(COQ8A):c.993C>T (p.Phe331=)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_020247.5(COQ8A):c.993C>T (p.Phe331=)
Variation ID: 3645 Accession: VCV000003645.63
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 1q42.13 1: 226982947 (GRCh38) [ NCBI UCSC ] 1: 227170648 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 11, 2015 Oct 20, 2024 Aug 1, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_020247.5:c.993C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_064632.2:p.Phe331= synonymous NC_000001.11:g.226982947C>T NC_000001.10:g.227170648C>T NG_012825.2:g.90412C>T LRG_1092:g.90412C>T LRG_1092t1:c.993C>T LRG_1092p1:p.Phe331= - Protein change
- -
- Other names
-
p.F331F:TTC>TTT
- Canonical SPDI
- NC_000001.11:226982946:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00559 (T)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
1000 Genomes Project 0.00559
1000 Genomes Project 30x 0.00562
Trans-Omics for Precision Medicine (TOPMed) 0.01261
The Genome Aggregation Database (gnomAD) 0.01390
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.01500
The Genome Aggregation Database (gnomAD), exomes 0.01566
Exome Aggregation Consortium (ExAC) 0.02091
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
COQ8A | - | - |
GRCh38 GRCh37 |
719 | 763 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Benign (5) |
criteria provided, multiple submitters, no conflicts
|
Jun 28, 2023 | RCV000003830.23 | |
Benign/Likely benign (6) |
criteria provided, multiple submitters, no conflicts
|
Aug 1, 2024 | RCV000415784.36 | |
Benign (5) |
criteria provided, multiple submitters, no conflicts
|
Mar 29, 2016 | RCV000180351.13 | |
Benign (1) |
criteria provided, single submitter
|
- | RCV001258271.3 | |
Benign (1) |
criteria provided, single submitter
|
Jun 6, 2023 | RCV003993734.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Benign
(Apr 12, 2015)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
unknown
|
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Accession: SCV000258150.2
First in ClinVar: Oct 11, 2015 Last updated: Oct 11, 2015 |
|
|
Benign
(Mar 29, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Accession: SCV000538237.1
First in ClinVar: Oct 11, 2015 Last updated: Oct 11, 2015 |
Comment:
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or … (more)
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: frequency in ExAC 2.8% in european population with (24 homozygotes). Also Benign in Clinvar (by GeneDx and Emory) (less)
Method: Genome/Exome Filtration
|
|
Benign
(Dec 17, 2014)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000232764.5
First in ClinVar: Jun 28, 2015 Last updated: Oct 11, 2015 |
Number of individuals with the variant: 1
Sex: mixed
|
|
Benign
(Jul 20, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Autosomal recessive ataxia due to ubiquinone deficiency
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002803569.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Benign
(Jan 31, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001724874.4
First in ClinVar: Jun 15, 2021 Last updated: Feb 20, 2024 |
|
|
Benign
(Jun 28, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Autosomal recessive ataxia due to ubiquinone deficiency
Affected status: unknown
Allele origin:
germline
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Accession: SCV000884981.5
First in ClinVar: Aug 04, 2018 Last updated: Feb 20, 2024 |
|
|
Likely benign
(-)
|
criteria provided, single submitter
Method: not provided
|
not provided
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Breakthrough Genomics, Breakthrough Genomics
Accession: SCV005263836.1
First in ClinVar: Sep 29, 2024 Last updated: Sep 29, 2024 |
|
|
Benign
(Aug 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV000493421.33
First in ClinVar: Jan 30, 2017 Last updated: Oct 20, 2024 |
Comment:
COQ8A: BP4, BP7, BS1, BS2
Number of individuals with the variant: 52
|
|
Benign
(Mar 06, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Autosomal recessive ataxia due to ubiquinone deficiency
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV000355249.3
First in ClinVar: Dec 06, 2016 Last updated: May 31, 2020 |
Comment:
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated … (more)
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. (less)
|
|
Benign
(-)
|
criteria provided, single submitter
Method: research
|
Joubert syndrome 17
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
Accession: SCV001435196.1
First in ClinVar: Oct 03, 2020 Last updated: Oct 03, 2020 |
Comment:
The c.993C>T (p.Phe331=) variant in ADCK3 has been identified in a French and Algerian individual with ubiquinone deficiency with cerebellar ataxia (PMID: 18319074), but has … (more)
The c.993C>T (p.Phe331=) variant in ADCK3 has been identified in a French and Algerian individual with ubiquinone deficiency with cerebellar ataxia (PMID: 18319074), but has also been identified in >4% of European (Finnish) chromosomes and 33 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In vitro functional studies provide some evidence that the c.993C>T variant may not impact protein function (PMID: 18319074). However, these types of assays may not accurately represent biological function. In summary, this variant meets criteria to be classified as benign for autosomal recessive ubiquinone deficiency with cerebellar ataxia. (less)
|
|
Benign
(Dec 04, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000166878.12
First in ClinVar: Jun 23, 2014 Last updated: Oct 11, 2015 |
Comment:
This variant is associated with the following publications: (PMID: 26764160, 27884173, 27535533, 18319074, 32337771)
|
|
Benign
(Jun 06, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Coenzyme Q10 deficiency
(Autosomal recessive inheritance)
Affected status: no
Allele origin:
germline
|
Molecular Genetics, Royal Melbourne Hospital
Additional submitter:
Shariant Australia, Australian Genomics
Accession: SCV004812795.1
First in ClinVar: Apr 15, 2024 Last updated: Apr 15, 2024 |
|
|
Pathogenic
(Mar 01, 2008)
|
no assertion criteria provided
Method: literature only
|
COENZYME Q10 DEFICIENCY, PRIMARY, 4
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000023995.3
First in ClinVar: Apr 04, 2013 Last updated: Nov 06, 2016 |
Comment on evidence:
In a patient of French and Algerian ancestry with CoQ10 deficiency-4 manifest as cerebellar ataxia (COQ10D4; 612016), Lagier-Tourenne et al. (2008) found compound heterozygosity for … (more)
In a patient of French and Algerian ancestry with CoQ10 deficiency-4 manifest as cerebellar ataxia (COQ10D4; 612016), Lagier-Tourenne et al. (2008) found compound heterozygosity for 2 mutations in the ADCK3 gene: a mutation in a predicted exonic splice enhancer in exon 8 (993C-T), and a 1645G-A transition in exon 14, resulting in a gly549-to-ser substitution (G549S; 606980.0011). The exon 8 mutation resulted in skipping of exon 8 leading to an in-frame deletion of 47 amino acids (Lys314_Gln360del). (less)
|
|
Benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
not specified
Affected status: yes
Allele origin:
germline
|
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001742409.3 First in ClinVar: Jul 07, 2021 Last updated: Sep 08, 2021 |
|
|
Likely benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Genome Diagnostics Laboratory, University Medical Center Utrecht
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001931737.1 First in ClinVar: Sep 26, 2021 Last updated: Sep 26, 2021 |
|
|
Benign
(Feb 25, 2016)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
unknown
|
Mayo Clinic Laboratories, Mayo Clinic
Accession: SCV000801931.1
First in ClinVar: Aug 04, 2018 Last updated: Aug 04, 2018 |
|
|
Benign
(-)
|
no assertion criteria provided
Method: clinical testing
|
not specified
Affected status: yes
Allele origin:
germline
|
Clinical Genetics, Academic Medical Center
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001924656.1 First in ClinVar: Sep 26, 2021 Last updated: Sep 26, 2021 |
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Autosomal recessive ataxia due to ubiquinone deficiency
Affected status: unknown
Allele origin:
germline
|
GeneReviews
Accession: SCV000494096.2
First in ClinVar: Nov 10, 2016 Last updated: Oct 01, 2022
Comment:
Causes the skipping of exon 8 leading to an in-frame deletion of 47 amino acids (p.Lys314_Gln360del) .
|
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Primary Coenzyme Q(10) Deficiency Overview. | Adam MP | - | 2023 | PMID: 28125198 |
ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. | Lagier-Tourenne C | American journal of human genetics | 2008 | PMID: 18319074 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=COQ8A | - | - | - | - |
Text-mined citations for rs41303129 ...
HelpRecord last updated Oct 20, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.